- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-1-1-mer
- Ligands
- 13 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 27 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.14: 3 residues within 4Å:- Chain A: E.132, N.164, N.165
Ligand excluded by PLIPNAG.15: 3 residues within 4Å:- Chain A: E.281, N.282
- Chain C: K.558
Ligand excluded by PLIPNAG.16: 1 residues within 4Å:- Chain A: N.603
Ligand excluded by PLIPNAG.17: 1 residues within 4Å:- Chain A: N.616
Ligand excluded by PLIPNAG.18: 1 residues within 4Å:- Chain A: N.657
Ligand excluded by PLIPNAG.19: 2 residues within 4Å:- Chain A: N.709, G.1131
Ligand excluded by PLIPNAG.20: 1 residues within 4Å:- Chain A: N.1134
Ligand excluded by PLIPNAG.21: 4 residues within 4Å:- Chain B: N.122, A.123, T.124, N.125
Ligand excluded by PLIPNAG.22: 1 residues within 4Å:- Chain B: N.165
Ligand excluded by PLIPNAG.23: 3 residues within 4Å:- Chain B: N.280, E.281, N.282
Ligand excluded by PLIPNAG.24: 2 residues within 4Å:- Chain B: N.331, Q.580
Ligand excluded by PLIPNAG.25: 1 residues within 4Å:- Chain B: N.603
Ligand excluded by PLIPNAG.26: 2 residues within 4Å:- Chain B: N.616, T.618
Ligand excluded by PLIPNAG.27: 1 residues within 4Å:- Chain B: N.657
Ligand excluded by PLIPNAG.28: 3 residues within 4Å:- Chain B: N.709, G.1131
- Chain C: D.796
Ligand excluded by PLIPNAG.29: 3 residues within 4Å:- Chain B: N.717, Q.926, Q.1071
Ligand excluded by PLIPNAG.30: 4 residues within 4Å:- Chain B: N.1098, T.1100, H.1101, F.1103
Ligand excluded by PLIPNAG.31: 1 residues within 4Å:- Chain B: N.1134
Ligand excluded by PLIPNAG.32: 3 residues within 4Å:- Chain C: N.280, N.282, T.284
Ligand excluded by PLIPNAG.33: 2 residues within 4Å:- Chain C: N.331, Q.580
Ligand excluded by PLIPNAG.34: 2 residues within 4Å:- Chain C: F.342, N.343
Ligand excluded by PLIPNAG.35: 1 residues within 4Å:- Chain C: N.603
Ligand excluded by PLIPNAG.36: 1 residues within 4Å:- Chain C: N.616
Ligand excluded by PLIPNAG.37: 1 residues within 4Å:- Chain C: N.657
Ligand excluded by PLIPNAG.38: 2 residues within 4Å:- Chain C: N.709, G.1131
Ligand excluded by PLIPNAG.39: 4 residues within 4Å:- Chain C: N.1098, T.1100, H.1101, F.1103
Ligand excluded by PLIPNAG.40: 1 residues within 4Å:- Chain C: N.1134
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wang, X. et al., A potent human monoclonal antibody with pan-neutralizing activities directly dislocates S trimer of SARS-CoV-2 through binding both up and down forms of RBD. Signal Transduct Target Ther (2022)
- Release Date
- 2022-04-06
- Peptides
- Spike glycoprotein: ABC
Light chain of Fab30: D
Heavy chain of Fab30: E - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
OE
P
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-1-1-mer
- Ligands
- 13 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 27 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wang, X. et al., A potent human monoclonal antibody with pan-neutralizing activities directly dislocates S trimer of SARS-CoV-2 through binding both up and down forms of RBD. Signal Transduct Target Ther (2022)
- Release Date
- 2022-04-06
- Peptides
- Spike glycoprotein: ABC
Light chain of Fab30: D
Heavy chain of Fab30: E - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
OE
P